PF-06751979

· Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PF-06751979, covering 2017-07-26 to 2018-11-01. Get the full timeline:

Most recent: Clinical Trial Update: First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979 [Phase 1]